Search for: "Pfizer, Inc., (Pfizer)" Results 981 - 1000 of 1,505
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Jul 2013, 4:00 am by Paula Bremner
” This admittedly strained analysis arises because the SCC took the rather novel approach of reviewing Pfizer’s Viagra patent by considering whether the person skilled in the art could determine what the “real compound” was that Pfizer had successfully tested and described anonymously in its patent. [read post]
27 Jan 2012, 4:00 am
However, the American company Pfizer Inc., proprietor of the earlier Community trade mark VIAGRA (registered in particular for a drug to treat erectile dysfunction), opposed that application.On the basis on that opposition, OHIM refused to register VIAGUARA as a Community trade mark. [read post]
11 Jan 2024, 12:03 am by Kurt R. Karst
The FIE determination released in fall 2023 involves the Reference Product AbbVie’s Humira (adalimumab) and two interchangeable biosimilars—first approved is Cyltezo (adalimumab-adbm), filed by Boehringer Ingelheim Pharmaceuticals, Inc, which was followed by Abrilada (adalimumab-afzb), filed by Pfizer. [read post]
17 Sep 2020, 4:55 am by Bob Ambrogi
Apple Inc. (9th Cir. 2020): “Employees receive no compensation for the time spent waiting for and undergoing exit searches, because they must clock out before undergoing a search. [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs)   Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in Maryland and Delaware… [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs)   Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in Maryland and Delaware… [read post]
22 Jun 2014, 9:01 pm by Ronald D. Rotunda
Recently, the news reported that Pfizer, Inc. wants to buy a British rival, AstraZeneca, PLC for nearly $100 billion. [read post]
25 Mar 2016, 3:16 pm by Schachtman
Hempstead sued the manufacturer of atorvastatin, Pfizer, Inc. [read post]
17 Apr 2012, 4:30 am
., Solutia, Inc., Pharmacia Corp., and Pfizer, Inc., in the Circuit Court of St. [read post]
10 Jul 2023, 6:47 am by Unknown
The SEC also brought charges against five individuals, including a Massachusetts police chief, in connection with their trading before the announcement of an offer by Alexion Pharmaceuticals Inc. to acquire Portola Pharmaceuticals Inc. [read post]
14 Sep 2010, 11:01 am by StephanieWestAllen
Lilly and Baker & Daniels are bringing the program to Shortridge students through a national organization called Street Law, Inc.Street Law, Inc. [read post]
9 Apr 2024, 3:12 am by John Jenkins
Defendant used highly confidential information about an impending announcement of the acquisition of biopharmaceutical company Medivation, Inc., the company where he worked, by Pfizer Inc. to trade ahead of the news for his own enrichment. [read post]
25 May 2016, 3:46 pm by Lyle Roberts
” In In re Pfizer Inc. [read post]